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AbsTRACT
Objective: To analyze the behavior of pH and sodium bicarbonate (NAHCO3) in the saliva of patients with leukemia 
during the administration protocol for Methotrexate (Mtx). Materials and Methods: A controlled clinical essay was 
carried out on 23 patients between 4 and 18 years of age with high-risk Acute Lymphoblastic Leukemia. Sampling was 
carried out at To: basal condition; T1: 12 hours after intravenous administration of sodium bicarbonate, before admin-
istering Mtx and T2: 3 hours after administering Mtx, the time of maximum concentration. Chiron-Diagnostic 378® 
equipment was used to determine pH and sodium bicarbonate. The data was interpreted using Analysis of Variance at 
the 5% significance level. Results: The highest values of sodium bicarbonate were observed at T2, with salivary pH levels 
remaining within neutrality ranges, diminishing slightly in T1. Conclusion. In this study, the dose of sodium bicarbonate 
considered in the administration protocol of 3 g /m2 Mtx, kept sodium bicarbonate levels in saliva at normal levels and 
pH neutral.   
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INTRODUCTION
The capacity of human saliva to stabilize acids is essential 
for maintaining pH in the oral environment above critical 
levels for hydroxyapatite to protect the teeth from demine-
ralization. The system responsible for the buffering capa-
city of human saliva includes bicarbonate, phosphate and 
proteins (1), with the bicarbonate buffer system being the 
most important (2).  It is believed that the transportation of 
bicarbonate to the salivary glands occurs via the changing 
mechanisms of bicarbonate/chlorine. The concentration of 
bicarbonate in the saliva is a consequence of the metabolic 
passage of CO2 through the salivary glands (1). CO2 is 
diffused freely through the epithelial boundary and, due to 
the presence of the protein carbonic anhydrase, acid neutra-
lization by the salivary bicarbonate is facilitated (3).  
The modification of the ecological equilibrium of the buccal 
cavity is related to the presence of systemic diseases or the 
administration of medication, all of which could produce 
quali-quantitative changes in the saliva (4-6), among which 
pH and sodium bicarbonate (NAHCO3) are worthy of 
mention (2). 
Clinical and forensic research has demonstrated that the 
salivary concentration of a substance may be related to 
its concentration in blood; the substances may pass from 
the plasma to saliva through intercellular or intracellular 
transportation. The latter could be by active transportation 
or by passive diffusion, which will depend on molecular 
weight, lipidic solubility, degree of ionization and proteic 
load. The mechanisms whereby a substance is transferred 
to saliva have an important implication for their use in 
              Article Number: 10489640
              © Medicina Oral S. L. C.I.F. B 96689336 - ISSN 1698-6946 
              eMail:  medicina@medicinaoral.com 
E436
Med Oral Patol Oral Cir Bucal. 2007 Oct 1;12(6):E435-9.                                                                                                                                          pH and salivary sodium bicarbonate in children with leukemia  Med Oral Patol Oral Cir Bucal 2007;                                                              12:E435-9.                                                                                                                                                         pH and salivary sodium bicarbonate in children with leukemia 
diagnosing (7). In the case of  a patient with cancer, the 
administration of acid substances such as Methotrexate in 
doses over 2 g/m2, requires the administration of alkaline 
substances such as sodium bicarbonate before and during 
72 hours in order to maintain hyperhydration and obtain 
alkaline diuresis, since the blood’s most important tampon 
uses bicarbonate – a basic compound in equilibrium with 
carbonic anhydride, an acid compound.
The more acid penetrates the blood, the more bicarbonate 
and the less CO2 are produced; on the other hand, the 
more the base penetrates the blood, the more CO2 and the 
less bicarbonate are produced; in both cases, the effect on 
pH is minimized (8), which could cause variations in pH 
and sodium bicarbonate levels in the saliva. A previous 
study concluded that the administration of methotrexate 
or cyclophosphamide did not modify the salivary buffering 
capacity in pediatric patients with cancer (9); these consi-
derations served as the basis for this study, the purpose of 
which was to analyze the behavior of sodium bicarbonate 
in the saliva of patients with high-risk acute lymphoblastic 
leukemia, the oncological treatment protocol of which uses 
high doses of Mtx.   
MATERIALs AND METHODs 
-Patients
The population was made up of the children and adolescents 
that attended the Oncohematological Unit of the Hospital 
de Especialidades Pediátricas (Hospital of Pediatric Special-
ties) (HEP), State of Zulia, Venezuela, between April 2004 
and May 2005. The sample comprised 23 patients ranging 
from 4 to 18 years of age.  Inclusion criteria: Patients must 
have been diagnosed with Acute Lymphoblastic Leukemia 
(ALL) in accordance with the French –American – British 
(FAB) (10), with indication to receive the Total XV Protocol 
of St Jude Children’s Research Hospital, which includes the 
administration of high doses of methotrexate (3g/m2) and 
hyperhydration with sodium bicarbonate (12 mEq/m2), 
during the consolidation phase (day 44, day 51) and ma-
intenance phase (weeks 10,20,24,31,39 and 47). Exclusion 
criterion: The presence of active carious cavities.   This study 
was approved by the Ethics Committee of the HEP; each 
parent or guardian signed an agreement report once the 
purpose therefore was explained to him or her.
-Saliva samples
Saliva samples were collected from the patients selected 
for the study during one of the cycles of the consolidation 
phase (day 44) or maintenance (weeks 10, 20, 24, 31 and 
47). The saliva was collected with the patient sitting upright 
and relaxed, stimulating saliva production by their chewing 
a paraffin capsule at three times: T0: basal condition, con-
sidered as the moment at which the administration of high 
doses of methotrexate has not been started; T1: 12 hours 
after beginning the administration of intravenous sodium 
bicarbonate and before administering Mtx; and T2: three 
hours after concluding the administration of Mtx, the time 
of maximum concentration (Table 1). In this study, ranges 
of pH will be considered within normal limits when values 
are between 6.0 and 7.5 (1) and salivary sodium bicarbonate 
levels of 5.8611 ± 2.7248 mmol/l (11). Chiron-Diagnostic 
378® equipment was used to determine pH and sodium 
bicarbonate, following the specifications of the manufac-
turer.
-Administering  chemotherapy 
Once authorized to receive high doses of Mtx, hyperhydra-
tion of the patient was begun with 12 mEq/m2  of sodium 
bicarbonate before and during the 72 hours following the 
administration of Mtx, with dose distributed in a single 
injection of   500 mg/m2, followed by  2.500 mg/m2  di-
luted in dextrose at 5%  for three hours, both indicated 
intravenously.  
-Statistical analysis  
The data was processed and analyzed with the Prisma 
Statistical Program, Version 4, using Analysis of Variance 
(ANOVA) at a 5% significance level in which the between-
subjects factor was age and the in-subject factor the eva-
luation times. 
REsULTs
The samples from 23 patients with ages ranging between 4 
and 18 years were analyzed. The patients were classified into 
four age groups: ≤ 5 (10 patients), from 5-10 (4 patients), 
10-15 (5 patients) and > 15 (4 patients).
-pH in  saliva 
The average values of pH in saliva  (Figure 1) showed no 
significant differences between T0, T1 and T2.  However, 
there is a slight decrease during T1. 
Figure 2 shows that the highest levels of  pH  observed 
during the study were located in the 10-15-year group and 
the lowest in the >15 group; likewise, this group showed the 
least difference between the averages of pH levels reached 
in T0 , T1 and T2.
No significant differences were found upon relating pH le-
vels during the different evaluation times and the age groups. 
On the other hand, in spite of the fact that higher pH levels 
were observed in the 5-10 and 10-15 age groups during the 
different evaluation times, no significant differences were 
detected between them. 
-Sodium bicarbonate in saliva
The behavior of bicarbonate levels in saliva was similar to 
that of salivary pH during the different treatment phases. 
The statistical test showed no significant differences. In 
Figure 3, a higher level of  salivary bicarbonate can be 
observed at T2 with respect to the levels at T0 and T1. The 
concentration of bicarbonate in saliva (Figure 4) showed 
a slight increase for the 10-15 age group and a decrease 
for the <15 age group in the different treatment phases. 
Bicarbonate concentration at T2 was above that observed 
at T0 and T1, except in the ≤5 age group, in which sodium 
bicarbonate concentration was slightly higher at T0. The 
greatest difference in sodium bicarbonate concentration 
was observed in the 10-15 age group, between T2 and the 
other evaluation times.
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3 h finishing the 












T0  basal condition
T1  B S Adm.











T1   B Sodio Admt.
T2  MTX Admt.  + BS
Table 1. Chemotherapy administration and times to collecting the saliva sample.
Fig. 1. Salivary pH according to times of evaluation.
Fig. 2.   Salivary pH according to age groups.
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DIsCUssION
The administration of Mtx produced no variations in pH 
and salivary sodium bicarbonate, differing from Olofsson 
et al (4), Ertugrul et al (5) and Al-Nowaiser et al (6), which 
could in this case be explained by the use, during the admi-
nistration protocol of the cytostatic agent, of an optimum 
dose of  sodium bicarbonate, thus maintaining levels of 
sodium bicarbonate within normal ranges and neutral pH 
in the saliva.  
Contrary to expectations, the lowest values of pH and sali-
vary bicarbonate were observed during the administration 
of the bicarbonate (T1), when chemotherapy administration 
was started. It is possible that, at central level, the action of 
psychological (12) or psychopathological (13) factors such 
as stress or anxiety –not considered in this study– could have 
caused a decrease in the salivary flow rate, which is very 
closely related to bicarbonate concentration (14). Although 
this study did not evaluate the salivary flow rate, it may be 
considered that the emotional aspect and not chemotherapy 
was probably responsible for this result, since chemotherapy 
may cause alterations that are usually temporary and less 
severe than those produced by radiotherapy as reported by 
Valicena and Escalona (15), who suggest that chemotherapy 
may produce changes in salivation, with total saliva presen-
ting modifications in composition or decreasing slightly. The 
increase in pH levels and bicarbonate during T2  could be 
related to bicarbonate concentrations in the blood, probably 
due to the continuous infusion received during 48 hours, 
time enough to allow the passage of sodium bicarbonate 
from the blood to the saliva (16).     
The levels of pH  at T0  decreased as the age of the patients 
under evaluation increased. The presence of local factors 
such as dental caries, plaque level and gingivitis could have 
influenced our findings; Zambrano et al (17) point out 
that these factors increase with age, which produces quali-
quantitative changes in the microbial flora of the saliva and 
induces a decrease in salivary pH.
It is thereby concluded that the dose of sodium bicarbonate 
considered in the administration protocol of 3 g /m2 of 
Mtx, kept the levels of sodium bicarbonate within normal 
ranges and neutral pH. It would be pertinent to continue 
with studies that could include measuring saliva flow rate 
and considering health-disease conditions in the mouth as 
variables moderating the parameters evaluated here, as well 
as the relationship between the values of pH and sodium 
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T1 B Sodio Admt.
T2  MTX Admt.+ BS
Fig. 3. Salivary sodium bicarbonate according to times of evaluation.
Fig. 4. Salivary sodium bicarbonate according to age groups.
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